| Literature DB >> 28381182 |
Haitao Bai1, Lili Zhou2, Chun Wang1, Xiaowei Xu1, Jieling Jiang1, Youwen Qin1, Xiaorui Wang1, Chuxian Zhao1, Shan Shao1.
Abstract
In this study, we investigated whether miR-125a participated in the resistance of the leukemia cell lines to the chemotherapeutic agent daunorubicin. Higher expression of miR-125a is correlated with lower treatment response and shorter overall survival in acute leukemia patients. Overexpression of miR-125a induced drug resistance in HL-60, K562, and THP-1cell lines through reducing apoptosis. We also showed that miR-125a mediated daunorubicin resistance in leukemia cell lines through the decrease of GRK2 and Puma which were proved to be direct targets of miR-125a. This study may provide novel therapeutic targets for therapy and improve predictions of therapeutic responses in leukemia to daunorubicin.Entities:
Keywords: MicroRNA-125a; apoptosis; daunorubicin; leukemia
Mesh:
Substances:
Year: 2017 PMID: 28381182 DOI: 10.1177/1010428317695964
Source DB: PubMed Journal: Tumour Biol ISSN: 1010-4283